IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
1. Preliminary Q4 revenue expected between $19.2M and $19.4M, marking record growth. 2. Full-year 2024 revenue estimated at $73.1M to $73.3M, up 11%-12% year-over-year. 3. Iradimed has achieved 14 consecutive quarters of record revenue. 4. Robust backlog and increased demand expected to continue into 2025. 5. Presentation at JPM Healthcare Conference scheduled for January 15, 2025.